Chronic Tempol Prevents Hypertension, Proteinuria, and Poor Feto-Placental Outcomes in BPH/5 Mouse Model of Preeclampsia
- 1 April 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 51 (4) , 1058-1065
Abstract
Recently we described a mouse model, BPH/5, that spontaneously develops the hallmark clinical features of preeclampsia. BPH/5 exhibit impaired placentation before the onset of hypertension and proteinuria, supporting a causal role for the placenta in the pathogenesis of preeclampsia. Here we tested the hypothesis that an increase in reactive oxygen species (ROS) early in pregnancy results in placental abnormalities leading to the maternal symptoms of preeclampsia. We further hypothesized that chronic antioxidant therapy would ameliorate both feto-placental abnormalities and maternal symptoms. ROS levels measured by dihydroethidium revealed significant increases in oxidative stress in BPH/5 placentas at midgestation compared with C57 controls. This increase in ROS was correlated with reduced expression and activity of cytoplasmic superoxide dismutase in early and midgestation BPH/5 placentas. These abnormalities in placental oxidant factors occurred before the onset of maternal symptoms, suggesting a possible causal link between increased ROS and maternal and feto-placental pathology in this model. In support of this, chronic treatment of BPH/5 with the superoxide dismutase-mimetic Tempol throughout gestation significantly improved fetal growth and survival. Furthermore, Tempol ameliorated pregnancy-induced increases in blood pressure and proteinuria in BPH/5 mothers. We confirmed that Tempol radical was present in plasma, and it normalized ROS levels in all placental zones in BPH/5. These data for the first time demonstrate an important causative role for increased ROS in the placenta in the pathogenesis of preeclampsia in a model that spontaneously develops the disease. The results also strongly suggest the potential utility of antioxidant therapy in treating preeclampsia.Keywords
This publication has 37 references indexed in Scilit:
- ESR imaging investigations of two‐phase systemsMagnetic Resonance in Chemistry, 2007
- Severe Feto-Placental Abnormalities Precede the Onset of Hypertension and Proteinuria in a Mouse Model of Preeclampsia1Biology of Reproduction, 2006
- Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockadeJournal Of Hypertension, 2006
- Vitamins C and E and the Risks of Preeclampsia and Perinatal ComplicationsNew England Journal of Medicine, 2006
- Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant RatHypertension, 2005
- Pathophysiological basis for the prophylaxis of preeclampsia through early supplementation with antioxidant vitaminsPharmacology & Therapeutics, 2005
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain RadiotherapyClinical Cancer Research, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Redox signaling in vascular angiogenesis1,2 1Guest Editor: Toshikazu Yoshikawa 2This article is part of a series of reviews on “Vascular Dysfunction and Free Radicals.” The full list of papers may be found on the homepage of the journal.Free Radical Biology and Medicine, 2002
- Is oxidative stress the link in the two-stage model of pre-eclampsia?The Lancet, 1999